Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (2TZ) Q3 2026 Earnings Report
DE:2TZ Q3 2026 EPS Results
- Actual EPS
- EUR 0.05
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- EUR 0.04
DE:2TZ Q3 2026 Revenue Results
- Actual Revenue
- EUR 127.92M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +0.32%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 10/30/2026
- Time
- Before Open
- Conference Call
- Friday, October 30, 2026
DE:2TZ Upcoming Earnings
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's next earnings date is estimated for April 1, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2TZ Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 01, 2027 | 2026 (Q4) | ―- | 0.07 | ― | ― |
| Oct 30, 2026 | 2026 (Q3) | ―0.05 | 0.04 | 26.83% (+0.01) | |
| Aug 14, 2026 | 2026 (Q2) | ―0.04 | 0.25 | -84.95% (-0.21) | |
| Apr 29, 2026 | 2026 (Q1) | ―0.07 | 0.06 | 19.40% (+0.01) | |
| Mar 30, 2026 | 2025 (Q4) | ―-0.00 | 0.23 | -101.55% (-0.23) | |
| Oct 30, 2025 | 2025 (Q3) | ―0.04 | 0.02 | 57.69% (+0.01) | |
| Aug 14, 2025 | 2025 (Q2) | ―0.25 | 0.04 | 469.39% (+0.21) | |
| Apr 29, 2025 | 2025 (Q1) | ―0.06 | 0.06 | -4.29% (-0.00) | |
| Mar 28, 2025 | 2024 (Q4) | ―0.23 | 0.02 | 1021.74% (+0.21) | |
| Oct 30, 2024 | 2024 (Q3) | ―0.02 | 0.02 | 8.33% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
